Short Summary
ProAmpac has filed an IPR petition seeking cancellation of all 15 claims of U.S. Patent 11,072,148, asserting anticipation and obviousness over four prior‑art references.
Detailed Summary
In a petition for Inter Partes Review (IPR2025‑01143), ProAmpac Holdings Inc. challenges the validity of every claim in U.S. Patent No. 11,072,148, which covers a recyclable packaging stack with a thin aluminum layer and protective coating. The petitioner contends that the invention is fully anticipated by the 2014 Gundlach publication and that the remaining claim scope is obvious when combining Gundlach with Yializis (2009), Rebouillat (2015), and the industry‑standard Voluntary Standard Reference (2013). Six distinct statutory grounds—anticipation under 35 U.S.C. § 102 and obviousness under § 103—are asserted, each mapping specific claim limitations to the cited references. No secondary considerations are presented, and the petition requests that the PTAB institute the IPR and cancel all claims.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in ProAmpac Holdings Inc. vs Sigma Technologies Int'l, LLC et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Rode Microphones, LLC et al.vsZaxcom, Inc.
The PTAB denied RØDE Microphones' request for rehearing of its institution denial, finding the petitioner failed to demonstrate any Board error regarding the interpretation of Strub’s genlocking technique.
Lenovo (United States) Inc. et al.vsHeadwater Research LLC
The PTAB denied institution of an IPR petition filed by Lenovo and Motorola against Headwater Research, finding that the petitioner failed to demonstrate a reasonable likelihood of prevailing on its obviousness grounds.
Genius Sports Ltd.vsSportsCastr Inc. (d/b/a PANDA Interactive)
The PTAB denied institution of the IPR petition filed by Genius Sports Ltd. against SportsCastr Inc., finding that Petitioner failed to establish a reasonable likelihood of prevailing on any challenged claim. The denial hinged on insufficient rationale for combining prior art references and specific claims not being supported by cited teachings.
Merck Sharp & Dohme LLCvsHalozyme, Inc. et al.
Halozyme has sought a Director Review of the PGR, and Merck has 5 business days to file a brief response without new evidence.
AZURITY PHARMACEUTICALS, INC.vsHelsinn Healthcare S.A.
Azurity has filed an IPR petition seeking cancellation of all 25 claims of Helsinn’s antiemetic patent (US 8,623,826) on the ground that the claims are obvious over multiple prior‑art references and that the asserted synergy is not unexpected.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.